HGF and pulmonary arterial hypertension: Transfer of human HGF may attenuate the inflammatory cell infiltrate, reduce the expression of inflammatory factors, and those effects are possibly due to the inhibition of EMV production which may decrease pulmonary vascular wall damage in PAH.